Skip to main content

. 1973 Mar;48(3):239–240. doi: 10.1136/adc.48.3.239

Severe cutaneous reactions to phenytoin.

PMCID: PMC1648100 PMID: 4266411

239

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

Dawson K. P., Jamieson A. Value of blood phenytoin estimation in management of childhood epilepsy. Arch Dis Child. 1971 Jun;46(247):386–388. doi: 10.1136/adc.46.247.386. [DOI] [PMC free article] [PubMed] [Google Scholar]
GROPPER A. L. Diphenylhydantoin sensitivity; report of fatal case with hepatitis and exfoliative dermatitis. N Engl J Med. 1956 Mar 15;254(11):522–523. doi: 10.1056/NEJM195603152541107. [DOI] [PubMed] [Google Scholar]
HELLER G., SLOANE M. Erythema bullosum malignans following dilantin therapy. Pediatrics. 1950 May;5(5):836–839. [PubMed] [Google Scholar]
Kutt H., McDowell F. Management of epilepsy with diphenylhydantoin sodium. Dosage regulation for problem patients. JAMA. 1968 Mar 11;203(11):969–972. [PubMed] [Google Scholar]
LIVINGSTON S. Treatment of epilepsy with diphenylhydantoin sodium (dilantin sodium). Postgrad Med. 1956 Dec;20(6):584–590. doi: 10.1080/00325481.1956.11691354. [DOI] [PubMed] [Google Scholar]

ACTIONS

RESOURCES